Skip to main content
. 2016 Feb 25;16:156. doi: 10.1186/s12885-016-2159-7

Fig. 1.

Fig. 1

Clinical outcome of S-1 for relapsed thymic carcinoma. a Best response of targeted lesions to S-1 treatment. b (i) and (ii) Kaplan–Meier analyses for PFS and OS of S-1 in refractory thymic carcinoma